Data as of Dec 19
| +0.0147 / +1.53%|
The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 3.75, with a high estimate of 3.75 and a low estimate of 3.75. The median estimate represents a +285.52% increase from the last price of 0.97.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.